Product How it works Pricing Blog FAQ About Contact
Español English
EspañolEnglish
Log inCreate free account
Labcorp

Labcorp (NYSE: LH) insider transactions

In the twelve months to 10 November 2026, executives and directors of Labcorp reported 22 open-market sales of 43,563 shares ($12.4m) and 0 open-market purchases, by 10 people, according to the Form 4 filings they submitted to the SEC.

Latest transactions

The 20 most recent transactions in Labcorp shares reported on Form 4
DateInsiderRoleTransactionSharesPriceHeld afterFiling
3 November 2026Vaughn Bryan TEVP and President, DiagnosticsOpen-market sale, 10b5-1 plan−306$353.706,845Form 4
2 November 2026Vaughn Bryan TEVP and President, DiagnosticsShares withheld for tax−194$355.597,151Form 4
2 November 2026Oyegunwa AkinboladeEVP, CIO & CTOShares withheld for tax−118$355.595,316Form 4
1 November 2026Vaughn Bryan TEVP and President, DiagnosticsOption exercise+500—7,345Form 4
1 November 2026Oyegunwa AkinboladeEVP, CIO & CTOOption exercise+370—5,434Form 4
30 October 2026Parham Richelle PDirectorOpen-market sale−1,078$361.222,288Form 4
17 August 2026Anderson Kerrii BDirectorOpen-market sale, 10b5-1 plan−3,000$318.026,563Form 4
11 August 2026Schechter Adam HPresident & CEOOpen-market sale, 10b5-1 plan−4,669$320.37102,565Form 4
4 August 2026Summy Amy B.EVP, Chief Marketing OfficerOpen-market sale−924$306.746,956Form 4
3 August 2026Wilkinson Peter JSVP, Chief Accounting OfficerOpen-market sale−82$309.221,770Form 4
3 August 2026Wilkinson Peter JSVP, Chief Accounting OfficerOption exercise+1,338$209.253,108Form 4
3 August 2026Wilkinson Peter JSVP, Chief Accounting OfficerOpen-market sale−1,338$309.231,770Form 4
2 July 2026Vaughn Bryan TEVP and President, DiagnosticsOpen-market sale, 10b5-1 plan−234$286.196,746Form 4
2 July 2026Kyle Kathryn WEVP, Chief Legal OfficerOpen-market sale, 10b5-1 plan−92$286.193,904Form 4
1 July 2026Vaughn Bryan TEVP and President, DiagnosticsOption exercise, 10b5-1 plan+327—7,073Form 4
1 July 2026Vaughn Bryan TEVP and President, DiagnosticsShares withheld for tax, 10b5-1 plan−93$283.886,980Form 4
1 July 2026Kyle Kathryn WEVP, Chief Legal OfficerOption exercise, 10b5-1 plan+256—4,069Form 4
1 July 2026Kyle Kathryn WEVP, Chief Legal OfficerShares withheld for tax, 10b5-1 plan−73$283.883,996Form 4
8 June 2026Kyle Kathryn WEVP, Chief Legal OfficerOpen-market sale, 10b5-1 plan−762$263.893,813Form 4
11 May 2026Schechter Adam HPresident & CEOOpen-market sale, 10b5-1 plan−5,903$254.50107,234Form 4

Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.

How to read the table

Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.

Where each row comes from

From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Labcorp page; the method, in data sources.

Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.